The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data.

@article{Penson2004TheEB,
  title={The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data.},
  author={David F Penson and Judd W. Moul and Christopher P Evans and John J Doyle and Sanjay Gandhi and Lois E. Lamerato},
  journal={The Journal of urology},
  year={2004},
  volume={171 6 Pt 1},
  pages={2250-4}
}
PURPOSE We evaluated the economic burden of metastatic and prostate specific antigen (PSA) progression in patients with prostate cancer (CaP) using a cancer registry linked administrative database. MATERIALS AND METHODS A retrospective cohort evaluation of 2056 patients with CaP was done at Henry Ford Health System from 1995 to 2000. Records were examined for metastatic progression via International Classification of Disease-9-CM codes for metastasis and for PSA progression using accepted… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Economic evaluation of diagnostic localization following biochemical prostate cancer recurrence.

International journal of technology assessment in health care • 2014
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…